Walleye Capital
AZN icon

Walleye Capital’s AstraZeneca AZN Stock Holding History

Walleye Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.78M Sell
44,500
-21,150
-32% -$4.08M 0.04% 463
2025
Q4 		$12.1M Buy
65,650
+32,100
+96% +$5.63M 0.04% 530
2025
Q3 		$5.15M Buy
33,550
+1,150
+4% +$174K 0.02% 909
2025
Q2 		$4.53M Sell
32,400
-950
-3% -$133K 0.02% 927
2025
Q1 		$4.9M Sell
33,350
-65,900
-66% -$9.53M 0.02% 799
2024
Q4 		$13M Buy
99,250
+6,900
+7% +$966K 0.03% 489
2024
Q3 		$14.4M Buy
92,350
+49,350
+115% +$7.97M 0.03% 499
2024
Q2 		$6.71M Sell
43,000
-60,300
-58% -$9.07M 0.01% 1055
2024
Q1 		$14M Sell
103,300
-15,850
-13% -$2.1M 0.02% 610
2023
Q4 		$16M Buy
119,150
+27,600
+30% +$3.59M 0.03% 433
2023
Q3 		$12.4M Buy
91,550
+32,500
+55% +$4.44M 0.03% 458
2023
Q2 		$8.45M Buy
59,050
+34,050
+136% +$5.01M 0.03% 461
2023
Q1 		$3.47M Buy
25,000
+22,100
+762% +$2.97M 0.05% 444
2022
Q4 		$393K Sell
2,900
-23,600
-89% -$2.96M 0.01% 1607
2022
Q3 		$2.91M Buy
+26,500
New +$3.36M 0.06% 382

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Walleye Capital's AZN Position: Q1 2026 in Review

Walleye Capital reduced its AstraZeneca (AZN) stake by 100% in Q1 2026, selling an estimated $42M and leaving 1 share worth $197. The position accounts for ﹤0.01% of the portfolio, ranked #4287.

Walleye Capital first reported a position in AZN in Q1 2019 and has held it in 12 quarters since. The position peaked at $40M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Walleye Capital held 1 share of AstraZeneca worth $197 as of Q1 2026.
  • Walleye Capital sold 217,697 AstraZeneca shares in Q1 2026, an estimated $42M.
  • AstraZeneca made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4287 holding.
  • Walleye Capital first reported a position in AstraZeneca in Q1 2019 and has held it in 12 quarters since.
  • Walleye Capital's AstraZeneca position peaked at $40M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.